Business Context and Reporting Period
This Form 8-K is a current report filed by Neuralstem, Inc. on September 18, 2014, regarding an event that occurred on September 13, 2014. The filing addresses a compensatory arrangement for a certain officer.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on executive compensation adjustments.
Material Changes
The Compensation Committee ratified a salary increase for Dr. Karl Johe, the Company's Chief Scientific Officer. His salary was set at $750,000, effective January 1, 2014. No other provisions of his employment agreement were changed.
Guidance, Outlook, and Risks
The filing contains no guidance, outlook, management commentary on business performance, risks, contingencies, or unusual items beyond the specific compensation adjustment noted above.
Investor Verification Points
- Verify the effective date of the salary increase (January 1, 2014) versus the ratification date (September 13, 2014).
- Confirm the total annual compensation impact of the $750,000 salary for the Chief Scientific Officer.
- Review the attached Exhibit 10.01 for the full text of the Employment Agreement Amendment.